Sotorasib (Brand Name: Lumakras) – A Breakthrough in KRAS G12C-Mutated Non-Small Cell Lung Cancer Treatment Sotorasib is a targeted cancer therapy that has transformed the treatment landscape for patients with…
What is Niraparib? Niraparib is an oral medication classified as a PARP inhibitor (Poly ADP-ribose polymerase inhibitor). It works by blocking the repair of damaged DNA in cancer cells, which…
Gilteritinib: Targeted Therapy for FLT3-Mutated AML Gilteritinib is a breakthrough oral medication used in the treatment of acute myeloid leukemia (AML), specifically for patients with a FLT3 gene mutation. As…
Osimertinib (Tagrisso): Advanced Treatment for EGFR-Positive Lung Cancer Osimertinib, marketed under the brand name Tagrisso, is a cutting-edge oral medication used primarily for the treatment of non-small cell lung cancer…
Reviews
There are no reviews yet.